Reviewed by PillSeek Editorial Team · Last updated
About This Medication
This medication is a Blue Oval 5 mm, Tablet with imprint "Par;034". It contains Meclizine hydrochloride 12.5 mg; of Meclizine hydrochloride[meclizine];. This belongs to the Antiemetic pharmacologic class. It is manufactured by Golden State Medical Supply, Inc.. For details please contact your physician.
Basic Information
- Imprint
- Par;034
- Color
- Blue
- Shape
- Oval
- Size
- 5 mm
Drug Information
- Strength
- Meclizine hydrochloride 12.5 mg;
- Dosage Form
- Tablet
Pharmaceutical Classification
- Pharmacologic Class
- Antiemetic
Related Medications
Other drugs in the same class: Antiemetic
- AntivertMECLIZINE HYDROCHLORIDE 12.5 mg;BLUE;WHITE • OVAL
- AntivertMECLIZINE HYDROCHLORIDE 25 mg;YELLOW;WHITE • OVAL
- AntivertMECLIZINE HYDROCHLORIDE 50 mg;YELLOW;BLUE • OVAL
- Meclizine HClMECLIZINE HYDROCHLORIDE 12.5 mg;WHITE • CAPSULE
- Meclizine HClMECLIZINE HYDROCHLORIDE 25 mg;RED • ROUND
- Meclizine HydrochlorideMECLIZINE HYDROCHLORIDE 12.5 mg;BLUE • OVAL
- Meclizine HydrochlorideMECLIZINE HYDROCHLORIDE 25 mg;YELLOW • OVAL
- MECLIZINE HYDROCHLORIDEMeclizine Hydrochloride 12.5 mg;BLUE • OVAL
- TIGANTRIMETHOBENZAMIDE 300 mgPURPLE • CAPSULE
- TIGANTRIMETHOBENZAMIDE HYDROCHLORIDE 300 mg;PURPLE • CAPSULE
Ingredients
- Active Ingredients
- Meclizine hydrochloride[meclizine];
- Inactive Ingredients
- Silicon dioxide;anhydrous lactose;magnesium stearate;cellulose, microcrystalline;sodium starch glycolate type a potato;starch, corn;stearic acid;fd&c blue no. 1;water;isopropyl alcohol;
Additional Information
- Manufacturer
- Golden State Medical Supply, Inc.
- Status (Rx/OTC)
- Otc
- Brand Names
- Antivert, Bonine, Dramamine Less Drowsy, Dramamine Nausea Relief, Verticalm, Wal-Dram 2, Zentrip
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.